ZYUS Life Sciences Corporation
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 481,000 | 351,000 | 298,000 | 207,000 |
| Operating Revenue | 481,000 | 351,000 | 298,000 | 207,000 |
| Cost Of Revenue | 352,000 | 180,000 | 530,000 | 64,000 |
| Gross Profit | 129,000 | 171,000 | -232,000 | 143,000 |
| Selling General And Administration | 9.3M | 12.6M | 9.4M | 13.1M |
| General And Administrative Expense | 9.1M | 12.3M | 8.8M | 12.1M |
| Research And Development | 2.0M | 1.3M | 2.2M | 5.4M |
| Depreciation And Amortization In Income Statement | 3.0M | 3.1M | 4.0M | 3.8M |
| Other Operating Expenses | 490,000 | 352,000 | 365,000 | 658,000 |
| Operating Expense | 14.8M | 17.4M | 16.1M | 22.9M |
| Operating Income | -14.7M | -17.2M | -16.3M | -22.8M |
| EBIT | -35.1M | -45.2M | -19.5M | -20.8M |
| Interest Expense | 755,000 | 3.3M | 5.2M | 2.7M |
| Interest Expense Non Operating | 755,000 | 3.3M | 5.2M | 2.7M |
| Net Interest Income | -1.1M | -3.8M | -5.5M | -2.7M |
| Other Income Expense | -20.1M | -27.4M | -3.0M | 1.9M |
| Other Non Operating Income Expenses | -- | -2.0M | 215,000 | 433,000 |
| Special Income Charges | -20.3M | -24.9M | -2.5M | 0.00 |
| Write Off | 1.1M | 2.2M | 406,000 | -- |
| Gain On Sale Of Security | 178,000 | -495,000 | -459,000 | 1.5M |
| Pretax Income | -35.9M | -48.4M | -24.7M | -23.6M |
| Tax Provision | -2.1M | -5.8M | -58,000 | -117,000 |
| Tax Effect Of Unusual Items | -1.2M | -3.1M | -6,937 | 7,475 |
| Net Income From Continuing And Discontinued Operation | -33.8M | -42.6M | -24.7M | -23.5M |
| Net Income From Continuing Operation Net Minority Interest | -33.8M | -42.6M | -24.7M | -23.5M |
| Net Income Including Noncontrolling Interests | -33.8M | -42.6M | -24.7M | -23.5M |
| Net Income Common Stockholders | -33.8M | -42.6M | -24.7M | -23.5M |
| Net Income | -33.8M | -42.6M | -24.7M | -23.5M |
| EBITDA | -32.2M | -42.1M | -15.4M | -17.1M |
| Normalized EBITDA | -12.1M | -16.6M | -12.5M | -18.6M |
| Reconciled Depreciation | 3.0M | 3.1M | 4.0M | 3.8M |
| Basic EPS | -0.47 | -0.76 | -0.35 | -0.34 |
| Diluted EPS | -0.47 | -0.76 | -0.35 | -0.34 |
| Basic Average Shares | 72.1M | 56.1M | 69.8M | 69.8M |
| Diluted Average Shares | 72.1M | 56.1M | 69.8M | 69.8M |
| Total Unusual Items | -20.1M | -25.4M | -3.0M | 1.5M |
| Total Unusual Items Excluding Goodwill | -20.1M | -25.4M | -3.0M | 1.5M |
| Tax Rate For Calcs | 0.06 | 0.12 | 0.00 | 0.00 |
| Normalized Income | -14.9M | -20.2M | -21.7M | -25.0M |
| Depreciation Amortization Depletion Income Statement | 3.0M | 3.1M | 4.0M | 3.8M |
| Diluted NI Availto Com Stockholders | -33.8M | -42.6M | -24.7M | -23.5M |
| Impairment Of Capital Assets | 19.2M | 22.8M | 2.1M | 0.00 |
| Net Income Continuous Operations | -33.8M | -42.6M | -24.7M | -23.5M |
| Net Non Operating Interest Income Expense | -1.1M | -3.8M | -5.5M | -2.7M |
| Other Gand A | 4.0M | 7.3M | 3.3M | 5.1M |
| Reconciled Cost Of Revenue | 352,000 | 180,000 | 530,000 | 64,000 |
| Salaries And Wages | 5.1M | 5.0M | 5.5M | 6.9M |
| Selling And Marketing Expense | 251,000 | 324,000 | 653,000 | 1.0M |
| Total Expenses | 15.2M | 17.5M | 16.6M | 23.0M |
| Total Operating Income As Reported | -35.0M | -42.1M | -18.8M | -22.8M |
| Total Other Finance Cost | 324,000 | 573,000 | 221,000 | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 1.9M | 4.0M | 212,000 | -- |
| Cash Cash Equivalents And Short Term Investments | 1.9M | 5.9M | 212,000 | -- |
| Cash Financial | 1.9M | 4.0M | 212,000 | -- |
| Other Short Term Investments | 0.00 | 1.9M | 0.00 | -- |
| Accounts Receivable | 52,000 | 161,000 | 199,000 | -- |
| Receivables | 366,000 | 627,000 | 243,000 | -- |
| Inventory | 630,000 | 2.0M | 4.2M | -- |
| Prepaid Assets | 275,000 | 311,000 | -- | -- |
| Other Current Assets | 189,000 | 556,000 | 1.6M | -- |
| Current Assets | 3.4M | 9.4M | 6.3M | -- |
| Gross PPE | 27.6M | 27.5M | 27.0M | -- |
| Accumulated Depreciation | -16.5M | -13.6M | -9.9M | -- |
| Net PPE | 11.2M | 13.9M | 17.0M | -- |
| Goodwill | 0.00 | 5.9M | 5.9M | -- |
| Goodwill And Other Intangible Assets | 0.00 | 18.2M | 41.3M | -- |
| Other Intangible Assets | -- | 12.3M | 35.4M | -- |
| Other Non Current Assets | 152,000 | 152,000 | 156,000 | -- |
| Total Non Current Assets | 11.3M | 32.2M | 58.4M | -- |
| Total Assets | 14.7M | 41.6M | 64.7M | -- |
| Current Debt | 9.1M | 6.1M | 899,000 | -- |
| Current Debt And Capital Lease Obligation | 9.5M | 6.6M | 1.2M | -- |
| Accounts Payable | 4.5M | 3.4M | 8.5M | -- |
| Payables | 4.5M | 3.4M | 8.5M | -- |
| Payables And Accrued Expenses | 7.9M | 6.7M | 13.0M | -- |
| Current Accrued Expenses | 3.4M | 3.3M | 4.5M | -- |
| Current Liabilities | 17.4M | 13.2M | 14.3M | -- |
| Long Term Debt | 371,000 | 637,000 | 30.8M | -- |
| Long Term Debt And Capital Lease Obligation | 2.6M | 3.3M | 33.7M | -- |
| Long Term Capital Lease Obligation | 2.3M | 2.6M | 2.9M | -- |
| Total Non Current Liabilities Net Minority Interest | 2.6M | 5.3M | 45.7M | -- |
| Total Liabilities Net Minority Interest | 20.0M | 18.5M | 60.0M | -- |
| Common Stock | 156.7M | 154.1M | 92.7M | -- |
| Capital Stock | 156.7M | 154.1M | 92.7M | -- |
| Additional Paid In Capital | 9.2M | 5.4M | 5.6M | -- |
| Retained Earnings | -174.0M | -140.2M | -97.6M | -- |
| Gains Losses Not Affecting Retained Earnings | 993,000 | 12,000 | 612,000 | -- |
| Other Equity Adjustments | 993,000 | 12,000 | 612,000 | -- |
| Common Stock Equity | -5.3M | 23.1M | 4.7M | -- |
| Stockholders Equity | -5.3M | 23.1M | 4.7M | -- |
| Total Equity Gross Minority Interest | -5.3M | 23.1M | 4.7M | -- |
| Total Capitalization | -5.0M | 23.8M | 35.5M | -- |
| Net Tangible Assets | -5.3M | 4.9M | -36.5M | -- |
| Tangible Book Value | -5.3M | 4.9M | -36.5M | -- |
| Working Capital | -14.0M | -3.9M | -8.0M | -- |
| Invested Capital | 4.1M | 29.9M | 36.4M | -- |
| Total Debt | 12.2M | 9.8M | 34.9M | -- |
| Net Debt | 7.6M | 2.8M | 31.5M | -- |
| Share Issued | 74.4M | 70.8M | 69.8M | -- |
| Ordinary Shares Number | 74.4M | 70.8M | 69.8M | -- |
| Buildings And Improvements | 2.7M | 2.7M | 2.6M | -- |
| Capital Lease Obligations | 2.7M | 3.0M | 3.2M | -- |
| Construction In Progress | 705,000 | 686,000 | 675,000 | -- |
| Current Capital Lease Obligation | 406,000 | 404,000 | 331,000 | -- |
| Current Notes Payable | 3.7M | 5.8M | 0.00 | -- |
| Derivative Product Liabilities | -- | 0.00 | 4.0M | -- |
| Finished Goods | 281,000 | 1.2M | 743,000 | -- |
| Land And Improvements | 881,000 | 881,000 | 881,000 | -- |
| Leases | 10.7M | 10.7M | 10.5M | -- |
| Line Of Credit | 81,000 | 0.00 | 697,000 | -- |
| Machinery Furniture Equipment | 1.2M | 1.2M | 1.2M | -- |
| Non Current Deferred Liabilities | 0.00 | 2.0M | 8.1M | -- |
| Non Current Deferred Taxes Liabilities | 0.00 | 2.0M | 8.1M | -- |
| Other Current Borrowings | 5.3M | 333,000 | 202,000 | -- |
| Other Equity Interest | 1.7M | 3.8M | 3.4M | -- |
| Other Inventories | 349,000 | 441,000 | 504,000 | -- |
| Other Properties | 11.5M | 11.3M | 11.1M | -- |
| Other Receivables | 1,000 | 3,000 | -- | -- |
| Properties | 0.00 | 0.00 | 0.00 | -- |
| Raw Materials | 0.00 | 368,000 | 2.9M | -- |
| Taxes Receivable | 313,000 | 463,000 | 44,000 | -- |
| Work In Process | 0.00 | 62,000 | 38,000 | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -9.9M | -17.9M | -9.6M | -16.9M |
| Cash Flow From Continuing Operating Activities | -9.9M | -17.9M | -9.6M | -16.9M |
| Depreciation And Amortization | 3.0M | 3.1M | 4.0M | 3.8M |
| Depreciation Amortization Depletion | 3.0M | 3.1M | 4.0M | 3.8M |
| Stock Based Compensation | 406,000 | 266,000 | 109,000 | 621,000 |
| Deferred Tax | -2.1M | -5.8M | -58,000 | -117,000 |
| Deferred Income Tax | -2.1M | -5.8M | -58,000 | -117,000 |
| Change In Working Capital | 1.7M | -4.8M | 2.6M | 2.2M |
| Changes In Account Receivables | 261,000 | -347,000 | 105,000 | 327,000 |
| Change In Receivables | 261,000 | -347,000 | 105,000 | 327,000 |
| Change In Inventory | 324,000 | -21,000 | 450,000 | -170,000 |
| Change In Payables And Accrued Expense | 704,000 | -5.1M | 2.3M | 1.9M |
| Change In Other Current Assets | -- | -64,000 | 0.00 | -- |
| Other Non Cash Items | 908,000 | 6.0M | 5.3M | 2.5M |
| Capital Expenditure | -46,000 | -281,000 | -560,000 | -5.0M |
| Purchase Of PPE | -46,000 | -281,000 | -560,000 | -5.0M |
| Net PPE Purchase And Sale | -46,000 | -281,000 | -560,000 | -5.0M |
| Purchase Of Business | -- | -- | -32,000 | -- |
| Sale Of Business | 0.00 | 4.9M | -- | -- |
| Purchase Of Investment | -- | -64,000 | -- | -- |
| Net Investment Purchase And Sale | 1.9M | -64,000 | -- | -- |
| Investing Cash Flow | 1.8M | 4.6M | -592,000 | -5.0M |
| Cash Flow From Continuing Investing Activities | 1.8M | 4.6M | -592,000 | -5.0M |
| Issuance Of Debt | 5.7M | 2.8M | 9.8M | 11.6M |
| Repayment Of Debt | -3.0M | -4.1M | -343,000 | -32,000 |
| Net Issuance Payments Of Debt | 2.7M | -1.3M | 9.5M | 11.6M |
| Issuance Of Capital Stock | 3.3M | 0.00 | 175,000 | 8,000 |
| Net Common Stock Issuance | 3.3M | 0.00 | 175,000 | 8,000 |
| Financing Cash Flow | 6.0M | 17.1M | 9.6M | 14.6M |
| Cash Flow From Continuing Financing Activities | 6.0M | 17.1M | 9.6M | 14.6M |
| Changes In Cash | -2.1M | 3.8M | -538,000 | -7.2M |
| Beginning Cash Position | 4.0M | 212,000 | 750,000 | 8.0M |
| End Cash Position | 1.9M | 4.0M | 212,000 | 750,000 |
| Free Cash Flow | -9.9M | -18.2M | -10.1M | -21.8M |
| Asset Impairment Charge | 20.3M | 24.9M | 2.5M | 0.00 |
| Change In Prepaid Assets | 403,000 | 736,000 | -272,000 | 81,000 |
| Common Stock Issuance | 3.3M | 0.00 | 175,000 | 8,000 |
| Gain Loss On Investment Securities | -- | 1.1M | 661,000 | -1.6M |
| Interest Paid Cfo | -168,000 | -226,000 | -114,000 | -900,000 |
| Long Term Debt Issuance | 0.00 | 1.9M | 8.8M | 5.6M |
| Long Term Debt Payments | -608,000 | -666,000 | -243,000 | -32,000 |
| Net Business Purchase And Sale | 0.00 | 4.9M | -32,000 | -- |
| Net Foreign Currency Exchange Gain Loss | -74,000 | 38,000 | -17,000 | 154,000 |
| Net Income From Continuing Operations | -33.8M | -42.6M | -24.7M | -23.5M |
| Net Intangibles Purchase And Sale | -- | -- | -32,000 | -4,000 |
| Net Long Term Debt Issuance | -608,000 | 1.3M | 8.5M | 5.6M |
| Net Other Financing Charges | -- | 18.4M | -- | -- |
| Net Short Term Debt Issuance | 3.3M | -2.6M | 940,000 | 6.0M |
| Operating Gains Losses | -74,000 | 1.2M | 644,000 | -1.4M |
| Proceeds From Stock Option Exercised | -- | -- | 0.00 | 3.0M |
| Purchase Of Intangibles | -- | -- | -32,000 | -4,000 |
| Short Term Debt Issuance | 5.7M | 850,000 | 1.0M | 6.0M |
| Short Term Debt Payments | -2.4M | -3.4M | -100,000 | 0.00 |